Iverscab 12mg Dispersible Tablet
By Iverscab
Rx
1 Tablet DT in a Strip

Composition
Ivermectin(12mg)

Manufacturer - NuLife Pharmaceuticals
203, Pleasant Apartments, 15th Lane, Prabhat Road, Pune 411004

Expires on or after
October, 2025

liver
Limited data is accessible regarding the utilization of Iverscab 12mg Dispersible Tablet in individuals with liver disease. It is advisable to seek guidance from your healthcare provider before starting this medication. Exercise caution when using Iverscab 12mg Dispersible Tablet 2's in patients with liver issues, and ensure you take it only as directed by a healthcare professional.

kidney
Limited information exists on using Iverscab 12mg Dispersible Tablet in kidney disease patients. Consult your doctor for guidance. Use V-Sys-12 DT Tablet 2's for kidney issues only as directed by your doctor.

alcohol
Caution It is not safe to drink alcohol while taking Iverscab 12mg Dispersible Tablet. Alcohol can interact with the medication, leading to more side effects.

driving
While driving, be cautious with V-Sys-12 DT Tablet 2 as it may cause drowsiness and impact driving ability. Iverscab 12mg Dispersible Tablet usually does not affect driving.

pregnancy
Iverscab 12mg Dispersible Tablet is potentially unsafe during pregnancy. Limited human studies indicate risks to the developing baby, as shown in animal studies. Consult your doctor before using, and inform them if you are pregnant or suspect pregnancy to evaluate benefits and risks effectively.

breastfeeding
Iverscab 12mg Dispersible Tablet is considered safe during breastfeeding based on limited data, indicating low risk to the baby. However, V-Sys-12 DT Tablet 2's should only be used if necessary. Consult your doctor for advice on the benefits and risks while breastfeeding.
Habit Forming | No |
Chemical Class | Macrocyclic Lactone Derivative |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Ectoparasiticides |
₹41.85
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025